A phase 1/2 study on safety of rovalpituzumab tesirine in combination with nivolumab or nivolumab + ipilimumab in small cell lung cancer
Scripture, C., Selvaggi, G., Lakatos, I., Boynton, K., Lally, S., Han, T.H., Peng, S.L., Dylla, S.J.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
Preliminary safety and efficacy of rovalpituzumab tesirine in patients with delta-like protein 3-expressing advanced solid tumors
Aggarwal, R., Mansfield, A., Beltran, H., Farago, A.F., Hann, C.L., Kaye, F., Lewis, K., Niu, J., Richey, S., Smith, D., Soares, H.P., Spira, A., Taylor, M., Waqar, S.N., Lally, S., Rossi, M., Saunders, L., Dylla, S.J., Kavalerchik, E., Anthony, L.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article